ATAI Life Sciences Commits to Bitcoin Investment Strategy with $5 Million Purchase, Boosting Stock Prices

ATAI Life Sciences Commits to Bitcoin Investment Strategy with $5 Million Purchase, Boosting Stock Prices
Biotech's ATAI Life Sciences Joins Roster of Firms With Bitcoin Treasury Strategies
1.48BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
NL0015000DX5
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.56
Dividend Share
-
Dividend Yield
-
Earnings Share
-2.84
Wall Street Target Price
14.00
EPS Estimate Current Year
-0.43
EPS Estimate Next Year
-0.46
EPS Estimate Current Quarter
-0.1119
EPS Estimate Next Quarter
-0.1032
Most Recent Quarter
-
Revenue TTM
3,488,000
Gross Profit TTM
-44,120,000
EBITDA
-120,710,000
Profit Margin
0.00%
Return On Assets TTM
-33.04%
Return On Equity TTM
-378.00%
Revenue Per Share TTM
0.013
Qtly Revenue Growth YOY
-38.70%
Diluted Eps TTM
-2.84
Qtly Earnings Growth YOY
-96.80%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
438.0424
Price Book MRQ
7.6901
Enterprise Value Revenue
372
Enterprise Value EBITDA
0
283.89
3.04%136.01
1.42%17.40
0.75%294.30
0.33%803.19
0.00%630.30
-11.57%434.31
-3.61%797.77
-2.91%147.30
-1.49%68.51
-0.71%